A Fluorescent hPept1 Transporter Substrate for Uptake Screening

Pharmaceutical Research

Volumn 20, Issue 11, 2003, Pages 1738-1745

  Landowski, Christopher P ^a   Han, Hyo Kyung ^a,b   Lee, Kyung Dall ^a   Amidon, Gordon L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PFIZER INC   (United States)

Author keywords

Caco 2; Fluorescent substrate; HeLa; hPept1; Oligopeptide transporter; Permeability

Indexed keywords

AMINO ACID DERIVATIVE; CARRIER PROTEIN; CEFALEXIN; DIPEPTIDE; FLUORESCEIN ISOTHIOCYANATE; GLYCINE; HUMAN INTESTINAL PEPTIDE TRANSPORTER; LYSINE; UNCLASSIFIED DRUG; VALINE;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

CACO-2 CELLS; CARRIER PROTEINS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HELA CELLS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYMPORTERS;

EID: 0344084057     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000003369.64891.51     Document Type: Article

References (16)

1. W. Kramer, C. Dechent, F. Girbig, U. Gutjahr, and H. Neubauer. Intestinal uptake of dipeptides and beta-lactam antibiotics. I. The intestinal uptake system for dipeptides and beta-lactam antibiotics is not part of a brush border membrane peptidase. Biochim. Biophys. Acta 1030:41-49 (1990).
2. + coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes. J. Pharmacol. Exp. Ther. 260:482-486 (1992).
3. M. Hu and G. L. Amidon. Passive and carrier-mediated intestinal absorption components of captopril. J. Pharm. Sci. 77:1007-1011 (1988).
4. M. A. Jacobson, P. de Miranda, D. M. Cederberg, T. Burnette, E. Cobb, H. R. Brodie, and J. Mills. Human pharmacokinetics and tolerance of oral ganciclovir. Antimicrob. Agents Chemother. 31: 1251-1254 (1987).
5. P. de Miranda and M. R. Blum. Pharmacokinetics of acyclovir after intravenous and oral administration. J. Antimicrob. Chemother. 12(Suppl B): 29-37 (1983).
6. S. Weller, M. R. Blum, M. Doucette, T. Burnette, D. M. Cederberg, P. de Miranda, and M. L. Smiley. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteers. Clin. Pharmacol. Ther. 54:595-605 (1993).
7. D. Jung and A. Dorr. Single-dose pharmacokinetics of valganciclovir in HIV-and CMV-seropositive subjects. J. Clin. Pharmacol. 39:800-804 (1999).
8. H. K. Han, D. M. Oh, and G. L. Amidon. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter. Pharm. Res. 15:1382-1386 (1998).
9. M. Sugawara, W. Huang, Y. J. Fei, F. H. Leibach, V. Ganapathy, and M. E. Ganapathy. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J. Pharm. Sci. 89:781-789 (2000).
10. D. E. Gonzalez, K. M. Covitz, W. Sadee, and R. J. Mrsny. An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2. Cancer Res. 58:519-525 (1998).
11. C. J. Whitaker, S. H. Battah, M. J. Forsyth, C. Edwards, R. W. Boyle, and E. K. Matthews. Photosensitization of pancreatic tumour cells by delta-aminolaevulinic acid esters. Anticancer Drug Des. 15:161-170 (2000).
12. D. A. Groneberg, F. Doring, P. R. Eynott, A. Fischer, and H. Daniel. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G697-G704 (2001).
13. H. Abe, M. Satoh, S. Miyauchi, S. Shuto, A. Matsuda, and N. Kamo. Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells. Bioconjug. Chem. 10:24-31 (1999).
14. C. P. Hsu, J. M. Hilfinger, E. Walter, H. P. Merkle, B. J. Roessler, and G. L. Amidon. Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction. Pharm. Res. 15:1376-1381 (1998).
15. H.-K. Han, R. L. A. de Vrueh, J. K. Rhie, K.-M. Y. Covitz, P. L. Smith, C.-P. Lee, D.-M. Oh, W. Sadee, and G. L. Amidon. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide. Pharm. Res. 15: 1154-1189 (1998).
16. E. Walter, T. Kissel, and G. L. Amidon. The intestinal peptide carrier: A potential transport system for small peptide derived drugs. Adv. Drug Deliv. Rev. 20:33-58 (1996).